These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2865148

  • 1. Beta-blockers and psychometric performance: studies in normal volunteers.
    McDevitt DG.
    Eur J Clin Pharmacol; 1985; 28 Suppl():35-8. PubMed ID: 2865148
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta-blockers on psychomotor performance in normal volunteers.
    Betts TA, Knight R, Crowe A, Blake A, Harvey P, Mortiboy D.
    Eur J Clin Pharmacol; 1985; 28 Suppl():39-49. PubMed ID: 2865149
    [Abstract] [Full Text] [Related]

  • 3. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
    Currie D, Lewis RV, McDevitt DG, Nicholson AN, Wright NA.
    Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
    [Abstract] [Full Text] [Related]

  • 4. Diazepam/beta-adrenoceptor antagonist interactions.
    Hawksworth G, Betts T, Crowe A, Knight R, Nyemitei-Addo I, Parry K, Petrie JC, Raffle A, Parsons A.
    Br J Clin Pharmacol; 1984 Aug; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
    [Abstract] [Full Text] [Related]

  • 5. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G, Grimes D, Muirhead C, Oshiro G.
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [Abstract] [Full Text] [Related]

  • 6. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR, Wolfel EE, Stoll S, Nies AS, Zerbe GO, Brammell HL, Horwitz LD.
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G, Ungethüm W, Pabst J, Simane Z, Bühring KU, Wiemann H.
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [Abstract] [Full Text] [Related]

  • 8. Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
    Nicholson AN, Wright NA, Zetlein MB, Currie D, McDevitt DG.
    Br J Clin Pharmacol; 1988 Aug; 26(2):129-41. PubMed ID: 2905149
    [Abstract] [Full Text] [Related]

  • 9. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E, Lucchesi BR.
    Pharmacology; 1984 Aug; 28(3):121-9. PubMed ID: 6144114
    [Abstract] [Full Text] [Related]

  • 10. Effects of cardioselective beta blockade on the peripheral lung in guinea pigs.
    Clerici C, Macquin-Mavier I, Harf A.
    Eur Respir J; 1988 Jan; 1(1):10-4. PubMed ID: 2896599
    [Abstract] [Full Text] [Related]

  • 11. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 12. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA, Dzimiri N.
    Eur J Pharmacol; 1992 May 14; 215(2-3):231-6. PubMed ID: 1356792
    [Abstract] [Full Text] [Related]

  • 13. Central effects of beta-adrenoceptor antagonists.
    Salem SA, McDevitt DG.
    Clin Pharmacol Ther; 1983 Jan 14; 33(1):52-7. PubMed ID: 6848299
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report.
    Kumar A, Khajuria V, Tandon VR, Kapoor B, Singh R.
    Indian J Physiol Pharmacol; 2007 Jan 14; 51(2):183-8. PubMed ID: 18175665
    [Abstract] [Full Text] [Related]

  • 15. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D, MacDonald IA, Heller SR, Tattersall RB.
    Br J Clin Pharmacol; 1990 Jun 14; 29(6):685-93. PubMed ID: 1974143
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL, Peele ME, Utiger RD.
    Endocrinology; 1984 Sep 14; 115(3):858-61. PubMed ID: 6146516
    [Abstract] [Full Text] [Related]

  • 17. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG, Shanks RG.
    Clin Pharmacol Ther; 1985 Nov 14; 38(5):554-9. PubMed ID: 2865028
    [Abstract] [Full Text] [Related]

  • 18. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L, Birkeland K, Nordby G, Larsen S, Kjekshus J.
    Br J Clin Pharmacol; 1991 Aug 14; 32(2):201-7. PubMed ID: 1681847
    [Abstract] [Full Text] [Related]

  • 19. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG, Brown HC, Carruthers SG, Shanks RG.
    Clin Pharmacol Ther; 1977 May 14; 21(5):556-66. PubMed ID: 15753
    [Abstract] [Full Text] [Related]

  • 20. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH, O'Connor PC, McNeill AJ, Finch MB, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1986 Mar 14; 21(3):249-58. PubMed ID: 2870732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.